Red cell alloimmunization in multi-transfused, oncology patients: Risks and management

Introduction: Repeated blood transfusion can result in the development of alloantibodies against one or more red cell antigens. Risk of alloimmunization is high in patients receiving multiple transfusions in hemoglobinopathies, hematologic malignancies, and cancer patients receiving chemotherapy. Ma...

Full description

Bibliographic Details
Main Authors: Sadhana Mangwana, Atin Kacker, Nikhil Simon
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Global Journal of Transfusion Medicine
Subjects:
Online Access:http://www.gjtmonline.com/article.asp?issn=2468-8398;year=2019;volume=4;issue=1;spage=74;epage=78;aulast=Mangwana